CORRECTED-UPDATE 1-Achillion partners with J&J to develop hep C drugs (May 19)
May 20, 2015 at 11:44 AM EDT
May 19 (Reuters) - Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.